|Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model|
RM Granich, CF Gilks, C Dye, KM De Cock, BG Williams
The Lancet 373 (9657), 48-57, 2009
|Antiretroviral Therapy for HIV Infection in Adults and Adolescents in Resource-Limited Settings: Towards Universal Access: Recommendations for a Public Health Approach|
C Gilks, M Vitoria
press. Geneva, Switzerland: World Health Organization, 2006
|The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings|
CF Gilks, S Crowley, R Ekpini, S Gove, J Perriens, Y Souteyrand, ...
The lancet 368 (9534), 505-510, 2006
|Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings|
G Meintjes, SD Lawn, F Scano, G Maartens, MA French, W Worodria, ...
The Lancet infectious diseases 8 (8), 516-523, 2008
|23–valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial|
N French, J Nakiyingi, LM Carpenter, E Lugada, C Watera, K Moi, ...
The Lancet 355 (9221), 2106-2111, 2000
|Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults|
N French, K Gray, C Watera, J Nakiyingi, E Lugada, M Moore, D Lalloo, ...
Aids 16 (7), 1031-1038, 2002
|TB/HIV: a clinical manual|
AD Harries, D Maher, S Graham, CF Gilks
World Health Organization, 2004
|A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults|
N French, S Gordon S, T Mwalukomo, S White, E Zijlstra ... C Gilks
New England Journal of Medicine 362 (9), 812-822, 2010
|Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial|
DART, Trial, team
The Lancet 375 (9709), 123-131, 2010
|Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya|
CF Gilks, RJ Brindle, RS Newnham, WM Watkins, PG Waiyaki, JBO Were, ...
The Lancet 336 (8714), 545-549, 1990
|The World Health Organization's global strategy for prevention and assessment of HIV drug resistance|
DE Bennett, S Bertagnolio, D Sutherland, CF Gilks
Antiviral therapy 13, 1, 2008
|Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment|
DE Bennett, M Myatt, S Bertagnolio, D Sutherland, CF Gilks
Antiviral therapy 13, 25, 2008
|Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1—positive persons in Uganda|
P Kaleebu, N French, C Mahe, D Yirrell, C Watera, F Lyagoba, J Nakiyingi, ...
The Journal of infectious diseases 185 (9), 1244-1250, 2002
|Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and …|
RK Gupta, A Hill, AW Sawyer, A Cozzi-Lepri, V von Wyl, S Yerly, VD Lima, ...
The Lancet infectious diseases 9 (7), 409-417, 2009
|Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence|
MA Gordon, HT Banda, M Gondwe, SB Gordon, MJ Boeree, AL Walsh, ...
Aids 16 (12), 1633-1641, 2002
|Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach|
EJ Schouten, A Jahn, D Midiani, SD Makombe, A Mnthambala, Z Chirwa, ...
The Lancet 378 (9787), 282-284, 2011
|Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults|
N French, J Nakiyingi, E Lugada, C Watera, JAG Whitworth, CF Gilks
Aids 15 (7), 899-906, 2001
|Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya|
CF Von Reyn, RD Waddell, T Eaton, RD Arbeit, JN Maslow, TW Barber, ...
Journal of clinical microbiology 31 (12), 3227-3230, 1993
|Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis|
P Nunn, R Brindle, K Wasunna, C Gilks, M Omwega, J Were, M Med, ...
The Lancet 337 (8742), 627-630, 1991
|The global fight against HIV/AIDS, tuberculosis, and malariacurrent status and future perspectives|
M Vitoria, R Granich, CF Gilks, C Gunneberg, M Hosseini, W Were, ...
American journal of clinical pathology 131 (6), 844-848, 2009